1278 related articles for article (PubMed ID: 1370679)
41. B7/CD28 but not LFA-3/CD2 interactions can provide 'third-party' co-stimulation for human T-cell activation.
Sansom DM; Wilson A; Boshell M; Lewis J; Hall ND
Immunology; 1993 Oct; 80(2):242-7. PubMed ID: 7505258
[TBL] [Abstract][Full Text] [Related]
42. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Linsley PS
J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
[TBL] [Abstract][Full Text] [Related]
43. Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL).
Zocchi MR; Poggi A; Heltai S; Villa A; Inverardi L; Vicari A; Sabbadini MG; Ferrarini M
Clin Exp Immunol; 1990 Oct; 82(1):108-13. PubMed ID: 1976463
[TBL] [Abstract][Full Text] [Related]
44. A co-stimulatory role for CD28 in the activation of CD4+ T lymphocytes by staphylococcal enterotoxin B.
Goldbach-Mansky R; King PD; Taylor AP; Dupont B
Int Immunol; 1992 Dec; 4(12):1351-60. PubMed ID: 1363054
[TBL] [Abstract][Full Text] [Related]
45. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.
Li Y; McGowan P; Hellström I; Hellström KE; Chen L
J Immunol; 1994 Jul; 153(1):421-8. PubMed ID: 7515929
[TBL] [Abstract][Full Text] [Related]
46. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
[TBL] [Abstract][Full Text] [Related]
47. Biased activation of human T lymphocytes due to low extracellular pH is antagonized by B7/CD28 costimulation.
Bosticardo M; Ariotti S; Losana G; Bernabei P; Forni G; Novelli F
Eur J Immunol; 2001 Sep; 31(9):2829-38. PubMed ID: 11536182
[TBL] [Abstract][Full Text] [Related]
48. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
49. Activation of human T lymphocytes through CD3 and CD2 (T11) with anti-CD3-coupled sheep erythrocytes.
Ocklind G
Scand J Immunol; 1988 May; 27(5):609-13. PubMed ID: 2897712
[TBL] [Abstract][Full Text] [Related]
50. Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.
Kobori H; Hashiguchi M; Piao J; Kato M; Ritprajak P; Azuma M
Immunology; 2010 Jul; 130(3):363-73. PubMed ID: 20141543
[TBL] [Abstract][Full Text] [Related]
51. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL
Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587
[TBL] [Abstract][Full Text] [Related]
52. Regulatory role of the CD8 antigen in both CD3 and CD2 monoclonal antibody-induced nonspecific cytotoxicity of class I- and class II-allospecific cytotoxic T cell clones.
Van Seventer GA; Van Lier RA; Kuijpers KC; Spits H; Melief CJ
Eur J Immunol; 1988 Dec; 18(12):1973-8. PubMed ID: 2905994
[TBL] [Abstract][Full Text] [Related]
53. Differential T cell costimulatory requirements in CD28-deficient mice.
Shahinian A; Pfeffer K; Lee KP; Kündig TM; Kishihara K; Wakeham A; Kawai K; Ohashi PS; Thompson CB; Mak TW
Science; 1993 Jul; 261(5121):609-12. PubMed ID: 7688139
[TBL] [Abstract][Full Text] [Related]
54. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.
Hombach A; Wieczarkowiecz A; Marquardt T; Heuser C; Usai L; Pohl C; Seliger B; Abken H
J Immunol; 2001 Dec; 167(11):6123-31. PubMed ID: 11714771
[TBL] [Abstract][Full Text] [Related]
55. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
[TBL] [Abstract][Full Text] [Related]
56. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
57. CD44 contributes to T cell activation.
Huet S; Groux H; Caillou B; Valentin H; Prieur AM; Bernard A
J Immunol; 1989 Aug; 143(3):798-801. PubMed ID: 2568380
[TBL] [Abstract][Full Text] [Related]
58. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
Damle NK; Doyle LV
J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
[TBL] [Abstract][Full Text] [Related]
59. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.
Ramarathinam L; Castle M; Wu Y; Liu Y
J Exp Med; 1994 Apr; 179(4):1205-14. PubMed ID: 7511683
[TBL] [Abstract][Full Text] [Related]
60. Application of anti-CD3-treated lymphocytes as stimulator cells in human autologous mixed lymphocyte cultures for generation of autorestricted CD8+ suppressor T cells.
Balashov KE; Brondz BD
Immunol Lett; 1992 Feb; 31(3):233-6. PubMed ID: 1347753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
